Pfizer’s RA drug on course for approval

An FDA advisory committee has recommended for approval Pfizer’s new rheumatoid arthritis treatment tofacitinib. The Arthritis Advisory Committee voted 8-2 to recommend approval of the drug for a…
Read the full story: InPharm